IRD Opus Genetics, Inc.
Company Analysis
Latest News
🟢 Opus Genetics is trading 6.58% up in pre-market after Phase 3 enrollment completion
Opus Genetics is trading 6.58% up in pre-market at $3.89 after renewed investor focus on its completed Phase 3 enrollment milestone for OPGx-LCA5. • The...
Opus Genetics Hits a Key Trial Milestone, But Can an Ultra-Rare Gene Therapy Justify Its $280 Million Bet?
Shares of Opus Genetics (IRD) surged 10.5% to $3.99 on August 17, buoyed by renewed investor focus on the company's completed enrollment in its pivotal...
🟢 Opus Genetics is trading 11% up in pre-market after completed Phase 3 OPGx-LCA5 enrollment
Opus Genetics is trading at $3.99 (+10.53%) in pre-market on August 17, 2026, after renewed attention to its completed enrollment in the registrational Phase 3...
🟢 Opus Genetics is trading 7.45% up in pre-market — no clear catalyst identified
Opus Genetics is trading 7.45% up at $4.04, with no clear company-specific catalyst identified for August 13, 2026. - The latest confirmed corporate update...
🟢 Opus Genetics is trading 5.5% up today — catalyst remains unclear
Opus Genetics is trading at $3.86, 5.46% up on August 11, 2026, but the catalyst remains unclear. - No new company announcement dated August 11 was...
🟢 Opus Genetics is trading 5.6% up today with no identified news catalyst
Opus Genetics is trading 5.6% up at $3.87, with no new August 11, 2026 company announcement or explicit news-to-price link identified. - The latest material...
🟢 Opus Genetics is trading 6.56% up today in pre-market with no clear company-specific catalyst identified
Opus Genetics is trading 6.56% up at $3.90 in pre-market, with no clearly reported August 11, 2026 company-specific catalyst identified. - August 6: The...
Opus Genetics, Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 12, 2026
For the second quarter of 2026, analysts expect Opus Genetics to report a consensus loss of $0.15 per share on revenue of $2.63 million, with the stock...
🔴 Opus Genetics is trading 5.69% down today after second-quarter revenue missed estimates
Opus Genetics is trading at $3.56, down 5.69%, after second-quarter revenue of $755,000 missed the $2.47 million estimate despite an EPS beat. - Reported an...
Opus Genetics second quarter results highlight clinical trial progress and a cash runway into 2029.
Opus Genetics reported second quarter collaboration revenue of $0.8 million and a net loss of $8.1 million, or ($0.08) per share. The clinical-stage...
🔴 Opus Genetics is trading 5.29% down in pre-market after second-quarter results on lower revenue
Opus Genetics is trading 5.29% down at $3.58 after reporting second-quarter 2026 results before the August 6, 2026 session, as revenue fell to $0.8 million...
🟢 Opus Genetics is trading 7.6% up today with no clear catalyst yet
Opus Genetics is trading at $3.99 (7.6% up) in pre-market with no clear catalyst yet, rebounding after closing at $3.71 on August 04. • Recent news flow...
🟢 Opus Genetics is trading 10.2% up today on strong momentum and risk-on market sentiment
Opus Genetics is trading 10.2% up now at $3.83 as the stock extends its late-July rally on strong trading momentum and positive sentiment, without fresh...
🟢 Opus Genetics is trading 5% up today on positive market sentiment and momentum
Opus Genetics is trading at $3.65 (5% up) as the stock maintains momentum following a sharp rally in late July. • The upward move occurs in the absence of...
🔴 Opus Genetics is trading 16.4% down today as it extends a pullback from its late-July rally
Opus Genetics is trading 16.4% down at $2.90 in pre-market, extending a sharp pullback after its late-July rally. • The move appears to be driven by traders...
🔴 Opus Genetics is trading 12% down today after a post-rally pullback
Opus Genetics is trading at $3.00 (-12.02%) in pre-market following a sharp pullback from its July 28 close of $3.41. • The downward move is described as a...
🔴 Opus Genetics is trading 6.2% down today as it pulls back after a three-day rally
Opus Genetics is trading 6.2% down at $3.20 in pre-market as the stock pulls back following a sharp three-day rally from $3.05 to $3.41. • The move appears to...
🟢 Opus Genetics is trading 5.8% up today amid broad biotech sector rally
Opus Genetics is trading 5.8% up today at $3.26 as the stock rebounds from a recent pullback, largely tracking a surge in the broader biotechnology...
🔴 Opus Genetics is trading 5.5% down today in a technical retrace
Opus Genetics is trading at $2.91 (5.5% down) in pre-market sessions as the stock undergoes a technical retrace following a recent recovery. • The move...
🟢 Opus Genetics is trading 7.1% up today with no clear catalyst
Opus Genetics is trading 7.1% up at $3.30 in pre-market, extending its recent rebound after closing at $3.08 on July 24. • The gain appears to be a technical...